Literature DB >> 31165578

Negative Cooperativity in NAD(P)H Quinone Oxidoreductase 1 (NQO1).

Clare F Megarity1, Hoda Abdel-Aal Bettley2, M Clare Caraher1,2, Katherine A Scott2, Roger C Whitehead3, Thomas A Jowitt4, Aldo Gutierrez5, Richard A Bryce2, Karen A Nolan2, Ian J Stratford2, David J Timson1,6.   

Abstract

NAD(P)H quinone oxidoreductase-1 (NQO1) is a homodimeric protein that acts as a detoxifying enzyme or as a chaperone protein. Dicourmarol interacts with NQO1 at the NAD(P)H binding site and can both inhibit enzyme activity and modulate the interaction of NQO1 with other proteins. We show that the binding of dicoumarol and related compounds to NQO1 generates negative cooperativity between the monomers. This does not occur in the presence of the reducing cofactor, NAD(P)H, alone. Alteration of Gly150 (but not Gly149 or Gly174) abolished the dicoumarol-induced negative cooperativity. Analysis of the dynamics of NQO1 with the Gaussian network model indicates a high degree of collective motion by monomers and domains within NQO1. Ligand binding is predicted to alter NQO1 dynamics both proximal to the ligand binding site and remotely, close to the second binding site. Thus, drug-induced modulation of protein motion might contribute to the biological effects of putative inhibitors of NQO1.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cancer-associated proteins; elastic network models; enzyme cooperativity; protein flexibility; quinone oxidoreductases

Mesh:

Substances:

Year:  2019        PMID: 31165578     DOI: 10.1002/cbic.201900313

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  7 in total

1.  Elucidation of Increased Cervical Cancer Risk Due to Polymorphisms in XRCC1 (R399Q and R194W), ERCC5 (D1104H), and NQO1 (P187S).

Authors:  Shrishty Tyagi; Nisha Chaudhary; Agneesh Pratim Das; Sandeep Saini; Subhash Mohan Agarwal
Journal:  Reprod Sci       Date:  2022-10-04       Impact factor: 2.924

Review 2.  Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1.

Authors:  Eduardo Salido; David J Timson; Isabel Betancor-Fernández; Rogelio Palomino-Morales; Ernesto Anoz-Carbonell; Juan Luis Pacheco-García; Milagros Medina; Angel L Pey
Journal:  J Pers Med       Date:  2022-05-05

3.  Allosteric Communication in the Multifunctional and Redox NQO1 Protein Studied by Cavity-Making Mutations.

Authors:  Juan Luis Pacheco-Garcia; Dmitry S Loginov; Ernesto Anoz-Carbonell; Pavla Vankova; Rogelio Palomino-Morales; Eduardo Salido; Petr Man; Milagros Medina; Athi N Naganathan; Angel L Pey
Journal:  Antioxidants (Basel)       Date:  2022-06-02

4.  Cancer-associated variants of human NQO1: impacts on inhibitor binding and cooperativity.

Authors:  Clare F Megarity; David J Timson
Journal:  Biosci Rep       Date:  2019-09-06       Impact factor: 3.840

5.  A Dynamic Core in Human NQO1 Controls the Functional and Stability Effects of Ligand Binding and Their Communication across the Enzyme Dimer.

Authors:  Pavla Vankova; Eduardo Salido; David J Timson; Petr Man; Angel L Pey
Journal:  Biomolecules       Date:  2019-11-12

6.  Structural basis of the pleiotropic and specific phenotypic consequences of missense mutations in the multifunctional NAD(P)H:quinone oxidoreductase 1 and their pharmacological rescue.

Authors:  Juan Luis Pacheco-Garcia; Ernesto Anoz-Carbonell; Pavla Vankova; Adithi Kannan; Rogelio Palomino-Morales; Noel Mesa-Torres; Eduardo Salido; Petr Man; Milagros Medina; Athi N Naganathan; Angel L Pey
Journal:  Redox Biol       Date:  2021-08-18       Impact factor: 11.799

7.  Virtual Screening for Potential Phytobioactives as Therapeutic Leads to Inhibit NQO1 for Selective Anticancer Therapy.

Authors:  Bhargav Shreevatsa; Chandan Dharmashekara; Vikas Halasumane Swamy; Meghana V Gowda; Raghu Ram Achar; Vivek Hamse Kameshwar; Rajesh Kumar Thimmulappa; Asad Syed; Abdallah M Elgorban; Salim S Al-Rejaie; Joaquín Ortega-Castro; Juan Frau; Norma Flores-Holguín; Chandan Shivamallu; Shiva Prasad Kollur; Daniel Glossman-Mitnik
Journal:  Molecules       Date:  2021-11-14       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.